Hello, welcome to Tosun!
会员中心

Product introduction:

Nicotinic acid sustained-release tablets, indications for patients at high risk of cardiovascular disease due to hypercholesterolemia, the use of lipid-lowering drugs is only one of a variety of interventions.

市场价:

  • Product information
  • 产品描述
  • 参数配置

Nicotinic acid sustained release tablets

Essential information:


Department: cardio cerebrovascular Department

[General Name] Niacin sustained release tablets

[Trade Name] Gozc

[Specification] 0.5g * 30 pieces / bottle * 300 bottles / piece

[Manufacturer] Hunan Sanjin Pharmaceutical Co., Ltd

[Approval No.] gyzz h20060727

[Unit] box


Product properties:

1. Three enterprises in China, new practice of low price medicine

2. Medical insurance class B, strictly controlled

3. Large development space and clear treatment effect


Details:

Nicotinic acid sustained-release tablets, indications for patients at high risk of cardiovascular disease due to hypercholesterolemia, the use of lipid-lowering drugs is only one of a variety of interventions. Nicotinic acid therapy can be used when dietary therapy and other non drug methods that limit saturated fatty acids and cholesterol intake are not effective. Before nicotinic acid treatment, the secondary causes of hypercholesterolemia (such as uncontrollable diabetes mellitus, hypothyroidism, nephrotic syndrome, albuminemia, obstructive liver disease, cholesterol level rise caused by other drugs, alcoholism) should be excluded, and the total cholesterol, HDL-C and triglyceride in blood should be measured.


[Usage and Dosage] take orally, 1000mg (two tablets 500mg) to 2000mg (two tablets 1000mg) once a day before going to bed

[Indications] this product can be used as an auxiliary treatment drug for exercise and diet control to reduce primary hypercholesterolemia.


Nicotinic acid sustained-release tablets, indications for patients at high risk of cardiovascular disease due to hypercholesterolemia, the use of lipid-lowering drugs is only one of a variety of interventions.

Effective reduction of primary hypercholesterolemia

热门关键词: 进口原料药代理 印度进口原料药 原料药关联审评 进口药品注册代理 国内参比制剂 美国参比制剂 原料药注册服务 原料药联合申报 原料药供应商
Copyright ©2020 Guangzhou Tosun Pharmaceutical Ltd 粤ICP备16102594号-2
MapsXML Maps  Maps
Phone

(86)18922121079

(86)18026299762

TOP